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Physicians should be alert for
relapsing fever in travelers, and this
diagnosis should be considered in
febrile patients from disease-endemic
regions. Diagnosis relies upon exami-
nation of stained blood smears. Where
available, molecular methods are
highly efficient to detect and identify
bacterial species. Other tickborne
infections (e.g., those with Rickettsia
spp.) should also be considered in
patients returning from disease-
endemic countries (8). The recom-
mended treatment is doxycycline,
although it can cause a Jarish-
Herxheimer reaction in some patients.
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Neonatal Moraxella
osloensis
Ophthalmia
To the Editor: Moraxella osloen-
sis is an aerobic, gram-negative, lac-
tose-nonfermenting coccobacillus. It
is a commensal of the human upper
respiratory tract and occasionally of
the skin and urogenital tract (1).
Unlike M. catarrhalis, M. osloensis is
rarely pathogenic in humans.
However, several cases of serious
infections caused by this organism
have been documented (2–6). While
cases of nongonococcal, nonchlamy-
dial, neonatal ophthalmia have been
reported in which the causative agent
was M. catarrhalis (7,8), to our
knowledge, this case is the first report
of neonatal ophthalmia due to M.
osloensis.
A 3-week-old, previously healthy
boy was seen at the emergency depart-
ment with a 48-hour history of yellow
drainage from and swelling in both
eyes. One day before admission, the
drainage increased; the child could not
open his eyes spontaneously. He had
been eating well and was normally
active. Aside from mild fussiness, no
other symptoms were noted.
The child was born full-term with-
out complications to a gravida 6, para
5–6 mother. He received normal new-
born care, including topical erythro-
mycin ointment to the eyes. Aside
from some mild jaundice at 6 days of
age, he had been healthy. The mother
denied any history of sexually trans-
mitted disease.
On examination, the infant’s tem-
perature was 38°C rectally, heart rate
144 beats/min, respirations 26/min,
and blood pressure 94/60 mm Hg. The
child appeared well developed and
was fussy but showed no symptoms
of toxicity. Both eyelids were marked-
ly swollen and erythematous, and a
yellow, purulent discharge was noted
bilaterally. The sclera and conjuncti-
vae were injected bilaterally. An oph-
thalmologist recorded that the red
reflex was intact bilaterally and the
corneas were clear. Intravenous cefo-
taxime, oral erythromycin, and topical
erythromycin ointment to the eyes
were recommended. The leukocyte
count was 11,400 cells/mm3 with a
normal differential. Hemoglobin
level, hematocrit, platelet count, and
bilirubin level were all within normal
range. Urinalysis results as well as
urine, blood, and cerebrospinal fluid
cultures were negative. Secretions
from the eyes were collected and sent
for Gram stain and bacterial culture as
well as chlamydial culture. Gram
stain showed few gram-variable
cocci.
The child’s eyes were flushed with
copious amounts of normal saline,
and a dose of intravenous cefotaxime
and ampicillin was administered in
the emergency department. He was
admitted to the hospital for presumed
ophthalmia neonatorum. The follow-
ing day, decreased lid swelling, ery-
thema, and eye discharge were
observed, with trace conjunctival
injection and minimal chemosis. 
The child’s condition improved
markedly during the next 24–48
hours. Cultures of the secretions
obtained from the eye grew presumed
Neisseria species as a pure culture.
The isolate was sent to the Allegheny
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County Health Department for further
testing and speciation. It was first test-
ed with a fluorescein-conjugated anti-
body for Neisseria gonorrhoeae;
results were negative. A RapID NH
panel (Remel, Lenexa, KS, USA) was
performed that identified the isolate
as M. osloensis with a 99.7% proba-
bility. Ideally, the isolate would have
undergone more comprehensive
genotypic and phenotypic characteri-
zation. However, as a presumed
Neisseria species, it was subjected to
the usual testing protocol at the health
department. Chlamydial culture was
performed by using buffalo green
monkey kidney cells (Viromed,
Minnetonka, MN, USA) grown under
standard conditions. No viral inclu-
sions were seen, and the culture did
not react with chlamydial antibodies
(Trinity Biotech, Bray, Ireland).
Because the child responded rapidly
to antimicrobial drug treatment, no
further workup of the bacterial isolate
was considered. The child was
healthy 3 days later and was dis-
charged to his home with topical
erythromycin and instructions to his
parents to follow up with his primary
care physician. 
Neonatal ophthalmia is a potential-
ly serious, sight-threatening infection
that may be caused by sexually trans-
mitted pathogens. Accordingly, this
clinical presentation warrants prompt
diagnosis and appropriate therapy. At
the same time, suspicion of a sexually
transmitted disease causes immense
social turmoil. Specific bacterial cul-
tures are essential for precise microbi-
ologic diagnosis and treatment. 
Cultures of conjunctival speci-
mens from our patient grew M.
osloensis. Clinically, this patient’s
infection was indistinguishable from
other causes of neonatal ophthalmia.
The differential diagnosis includes
other agents such as N. gonorrhoeae,
Chlamydia trachomatis, M. catarr-
halis, Staphylococcus aureus, Haemo-
philus influenzae, and Streptococcus
pneumoniae. Rarely, gram-negative
enteric organisms may be implicated
(9). Viruses, such as adenovirus or
herpesvirus, are also a potential cause
but were unlikely in this case.
Finally, social issues must be con-
sidered. When an infant is seen with
neonatal ophthalmia, a physician will
often presume it to be gonococcal or
chlamydial and assume the mother is
positive for these infections. Recog-
nizing that Moraxella species, includ-
ing M. osloensis, may produce an
identical clinical picture should limit
presumptions regarding sexually
transmitted diseases until a precise
microbiologic diagnosis is made. 
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African Tick-bite
Fever in French
Travelers
To the Editor: African tick-bite
fever (ATBF) is caused by Rickettsia
africae and remains the most common
tickborne rickettsiosis in sub-Saharan
Africa (1,2). We describe an outbreak
of ATBF in 10 of 34 French tourists
on their return from South Africa in
March 2005. Fever, skin rash, and
multiple eschars on the legs devel-
oped in the index case-patient (patient
9, Table). After informed consent was
obtained, the tourists completed a
questionnaire for epidemiologic and
clinical data. Acute- and convales-
cent-phase serum samples were col-
lected when possible for serologic
analysis performed at the Unité des
Rickettsies. The samples were tested
against a panel of antigens including
R. typhi, Francisella tularensis,
Coxiella burnetii, Borrelia burgdor-
feri, Anaplasma phagocytophylum, R.
felis, R. helvetica, R. conorii subsp.
conorii strain Malish, R. africae, R.
sibirica mongolotimonae, R. massili-
ae, and R. slovaca, as previously
described (3). A case of symptomatic
confirmed ATBF was defined as
clinical illness and positive serologic
results against R. africae, whereas a
case of probable ATBF was defined as
typical clinical symptoms without
